|
273 Regulatory
review should consider fitness for purpose Consideration should
be given to the overall fitness for purpose of the current regulatory
framework for the non-medical health professions, the Royal Pharmaceutical
Society has said ...more
273 Open
chlamydia screening bids to all, says NPA The National Pharmacy
Association said this week that it would expect the national roll out
of free chlamydia screening through community pharmacies to be open to
all NPA members ...more
273 Sharp rise
in prosecutions for assault of NHS workers There has been
a 15-fold increase in one year in the number of prosecutions of people
who assault NHS workers ...more
274 Homoeopathy
effects are no better than placebo The clinical effects of
homoeopathy are placebo effects, according to research published in The
Lancet last week ...more
274 Ayurvedic
remedies warning Ayurvedic medicines on the UK market may
contain high levels of heavy metals, such as mercury, arsenic and lead,
warns the Medicines and Healthcare products Regulatory Agency ...more
274 Placebo activates
brain pain response Administration of a placebo with implied
analgesic properties activates brain areas involved in suppressing pain,
a study has found ...more
274 Bowel cancer
screening programme for Scotland Men and women in Scotland aged between 50 and 74 years will be screened for bowel cancer every two years under an initiative announced this week
...more
274 New arrangements
for stoma appliance supply Community pharmacists and appliance
contractors in Scotland who wish to supply stoma appliances after April
2006 will shortly be asked to respond to a procurement process ...more
274 Benzodiazepines
for withdrawal Benzodiazepines offer an 84 per cent decrease
in risk of seizures related to alcohol withdrawal compared with placebo,
a Cochrane systematic review has concluded. However, the authors say
that there are insufficient data to conclude whether benzodiazepines
are more effective than other drugs used in alcohol withdrawal ...more
274 Evidence-based
medicine Reviews of the evidence behind the use of drugs to
treat specific conditions are the focus of a new international peer-reviewed
journal ...more
|
275 Society proposes
hard line on returning to practice Health professionals who
have been out of practice for more than five years may be regarded as
being unfit ever to practise again, the Royal Pharmaceutical Society
has told the Health Professions Council ...more
275 Web pharmacies
put people's lives at risk, think-tank concludes People's
lives are at risk unless the Government does something to prevent prescription
medicines being sold via the internet without proper safeguards or controls.
This is the conclusion of a seminar hosted by the Centre for Reform think-tank
...more
275 Pharmacy
should be involved in European child research plans Specialist
paediatric pharmacists should be involved in the operation of European
plans to make more licensed medicines available for the treatment of
children, the Royal Pharmaceutical Society says ...more
276 Potential
lamotrigine and COC interaction questioned A possible interaction
between lamotrigine and the combined oral contraceptive pill has been
called into question by the Faculty of Family Planning and Reproductive
Health Care clinical effectiveness unit ...more
276 Early statin
use decreases risk of mortality in acute MI Use of a statin
within 24 hours of admission to hospital for acute myocardial infarction
lowers the rate of early complications and mortality, researchers suggest
...more
276 Frequent,
long-term paracetamol use could double women’s risk of hypertension Paracetamol
use may almost double the risk of developing hypertension among women
taking more than 500mg daily over five years, irrespective of age, according
to a new analysis from the Nurses Health Study published this week ...more
276 Docetaxel
demonstrates improved survival in breast cancer, compared with paclitaxel The
first direct comparative study of the taxanes has found better survival
in advanced breast cancer for those taking docetaxel compared with those
taking paclitaxel at the standard doses of the two drugs ...more
|
The
Pharmaceutical Journal